ENT-ATORVASTATIN

UNII:	U2H272PQ8B
Type:	INGREDIENT SUBSTANCE
Formula:	C₃₃H₃₅FN₂O₅
Preferred Substance Name:	ENT-ATORVASTATIN
InChIKey:	XUKUURHRXDUEBC-SVBPBHIXSA-N
GSRS Full Record:	U2H272PQ8B i

501121-34-2
(3S,5S)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
(βS,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid
1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (βS,δS)-
3S,5S-Atorvastatin
Atorvastatin calcium Impurity E [EP IMPURITY]
Ent-atorvastatin

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ENT-ATORVASTATIN

Synonyms and Mappings

Resources